Health Condition 1: - Health Condition 2: N189- Chronic kidney disease, unspecified
Conditions
Interventions
Intervention1: Interventional Group: STEP 1: BASELINE ASSESSMENT
Patient demographics details.
Medication history, Lab results.
STEP 2: RISK STRATIFICATION
Assess co-morbidities (example: Diabetes, hy
Sponsors
Dr A Gowtham
Eligibility
Inclusion criteria
Inclusion criteria: Adults patients greater than 18 years, who are diagnosed with CKD based on KDIGO (stage 2 to 5), including dialysis patients. All comorbidity patients should be included.
Exclusion criteria
Exclusion criteria: Severe cognitive impairment or psychiatric disorders affecting the ability to participate in care. Pregnant or lactating women. Inability to adhere to treatment recommendations due to social, economic, or other barriers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO EVALUATE THE EFFECTIVENESS OF CLINICAL PHARMACIST INTERVENTION: 1.Drug-related problems will be assessed by using PCNE version 9.1 2. Patient health-related quality of life will be assessed by using FANLTC scale 3. Patient medication adherence improvement will be assessed by using MARS-10.Timepoint: At baseline, 3rd month and 6th month | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in clinical parameters, such as blood pressure, HbA1c, electrolytes, Complete blood count, etc...Timepoint: Six months | — |
Countries
India
Contacts
Public ContactDr A Gowtham
Karpagam Academy of Higher Education
Outcome results
None listed